BNP Paribas Financial Markets’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,267,838
| Closed | -$225M | – | 4450 |
|
|
2020
Q1 | $225M | Buy |
1,267,838
+369,949
| +41% | +$69.7M | 0.46% | 33 |
|
|
2019
Q4 | $172M | Buy |
897,889
+554,726
| +162% | +$100M | 0.31% | 59 |
|
|
2019
Q3 | $57.8M | Sell |
343,163
-37,784
| -10% | -$6.16M | 0.1% | 198 |
|
|
2019
Q2 | $63.8M | Sell |
380,947
-97,893
| -20% | -$13.6M | 0.13% | 172 |
|
|
2019
Q1 | $70.1M | Sell |
478,840
-317
| -0.1% | -$46K | 0.15% | 145 |
|
|
2018
Q4 | $64M | Sell |
479,157
-77,239
| -14% | -$12.7M | 0.15% | 149 |
|
|
2018
Q3 | $106M | Buy |
556,396
+48,324
| +10% | +$8.88M | 0.16% | 128 |
|
|
2018
Q2 | $84.7M | Buy |
508,072
+298,992
| +143% | +$48M | 0.14% | 145 |
|
|
2018
Q1 | $35.2M | Sell |
209,080
-47,799
| -19% | -$8.02M | 0.07% | 280 |
|
|
2017
Q4 | $42M | Sell |
256,879
-111,497
| -30% | -$20M | 0.07% | 242 |
|
|
2017
Q3 | $75.5M | Buy |
368,376
+26,212
| +8% | +$6.1M | 0.18% | 105 |
|
|
2017
Q2 | $83.2M | Sell |
342,164
-84,225
| -20% | -$19.8M | 0.25% | 85 |
|
|
2017
Q1 | $102M | Buy |
426,389
+309,995
| +266% | +$72.2M | 0.27% | 77 |
|
|
2016
Q4 | $24.4M | Sell |
116,394
-38,635
| -25% | -$8M | 0.11% | 158 |
|
|
2016
Q3 | $35.7M | Buy |
155,029
+26,245
| +20% | +$6.41M | 0.15% | 113 |
|
|
2016
Q2 | $29.8M | Sell |
128,784
-180,476
| -58% | -$41.6M | 0.13% | 107 |
|
|
2016
Q1 | $82.9M | Sell |
309,260
-96,145
| -24% | -$27.5M | 0.35% | 54 |
|
|
2015
Q4 | $127M | Buy |
405,405
+7,971
| +2% | +$2.37M | 0.31% | 63 |
|
|
2015
Q3 | $108M | Buy |
+397,434
| New | +$122M | 0.27% | 58 |
|
|
2015
Q2 | – | Sell |
-129,695
| Closed | -$55.7M | – | 3668 |
|
|
2015
Q1 | $55.7M | Buy |
129,695
+13,782
| +12% | +$3.93M | 0.15% | 88 |
|
|
2014
Q4 | $29.8M | Sell |
115,913
-7,073
| -6% | -$1.77M | 0.11% | 163 |
|
|
2014
Q3 | $29.7M | Buy |
122,986
+637
| +0.5% | +$143K | 0.03% | 248 |
|
|
2014
Q2 | $27.3M | Buy |
122,349
+55,036
| +82% | +$11.4M | 0.03% | 218 |
|
|
2014
Q1 | $13.8M | Sell |
67,313
-27,323
| -29% | -$5.41M | 0.01% | 383 |
|
|
2013
Q4 | $15.9M | Sell |
94,636
-32,462
| -26% | -$5.07M | 0.01% | 349 |
|
|
2013
Q3 | $18.3M | Buy |
127,098
+114,897
| +942% | +$15.3M | 0.01% | 343 |
|
|
2013
Q2 | $1.54M | Buy |
+12,201
| New | +$1.38M | ﹤0.01% | 826 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
BNP Paribas Financial Markets's AGN Position: Q2 2020 in Review
BNP Paribas Financial Markets sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,267,838 shares — an estimated $225M sold.
BNP Paribas Financial Markets first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $225M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- BNP Paribas Financial Markets reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1,267,838 Allergan plc shares in Q2 2020, an estimated $225M.
- BNP Paribas Financial Markets first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
- BNP Paribas Financial Markets's Allergan plc position peaked at $225M in Q1 2020.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.